Search results
Opiant Pharma Secures Additional BARDA Funding For Opioid Overdose Treatment
Benzinga via Yahoo Finance· 2 years agoThe Biomedical Advanced Research and Development Authority (BARDA) has awarded an additional...
OraSure Secures BARDA Funding For Next-Gen Ebola Diagnostic Test
Benzinga via Yahoo Finance· 2 years agoThe Biomedical Advanced Research and Development Authority (BARDA) has issued an $8.6 million...
OPKO Health (OPK) Gets BARDA Contract to Combat Antibody Threats
Zacks via Yahoo Finance· 9 months agoOPKO Health's (OPK) latest awarded funding is likely to enable the development of novel...
GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the...
NewMediaWire via Yahoo Finance· 1 week ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen,...
BARDA Exercises First Contract Option With Marinus Pharma For Its Epilepsy Candidate
Benzinga via Yahoo Finance· 2 years agoMarinus Pharmaceuticals Inc (NASDAQ: MRNS) announced that the Biomedical Advanced Research and...
Vir Biotechnology Inc (VIR) Reports Q3 2023 Financial Results
GuruFocus.com via Yahoo Finance· 8 months agoVir Biotechnology Inc (NASDAQ:VIR) reported Q3 2023 financial results on November 2, 2023. The...
Enalare Secures BARDA Award Of $50M For ENA-001 In Drug Overdose
Benzinga via Yahoo Finance· 2 years agoEagle Pharmaceuticals Inc (NASDAQ: EGRX) announced that Enalare Therapeutics Inc secured a contract...
US government to fund up to $500 million for studies on oral, nasal COVID vaccines
Reuters via Yahoo Finance· 2 weeks agoThe funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced...
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 2 weeks agoCyanVac has received US federal funding through the Project NextGen initiative to conduct a Phase...
Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering
Benzinga via Yahoo Finance· 2 weeks agoVaxart, Inc. (NASDAQ:VXRT) shares traded higher in the premarket session on Friday, up more than 23%...